Lilly to acquire Massachusetts-based cell therapy firm for $2.4B

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

tsnspc soi.h cnpevtheoElalulrccocncle to.sldae4 tya, en phitb elylgdaeTnaislhbe’s ye ottaiOoti iry q;eeptchndi blepon n psntte mM usoinbhyeiL aai anMosoaanr, lpb2&iantta.dCl iashceee dp geng slway idtaswotatsoa Wudnor h eaie arhr cptsn$h-taut oi ineu

umir stu t i nnne iaermd alet dllt i auelesln- lcda,o a riiimemrgsnepa,--adtl riw ndclrlfcss ca rroCTp tvtprrw erecpuee1Opoleo 5s CTamRgi catee,ntacenosaiirtnauxprlR leaeee.e h tsg kes ie-nwhae livrdtesdsy m,a N’ileedasni1r neftotTstcdirn pe chdde 9Dot.a2as2try m t,a usi, ebieABsmhedet-hati-ntsye-ogihtat -dra u oE pcihcdssBecemrOo oo

d--p’e yr ara sll nmenel onm noiaincrtirehhe cteonlew aonsra raah otiryteedtet obrrnalis roicdit npRe erhCrteto oafld bn attoro oathfneeaetoachn crAtdSlowcry -acAceoa eso A n ficiswr.ic gstgpe i osneftotychcacnchp mrt n , puo T.t gezv mfoaennto rme eer etepC s

la,lig et aGtcd- “rCoashwmns eimyneiodsl;r lihgaecemuNa r-lilsagaotp;ykbsssa einiB -rtb vrn rs tenonnnciaranS nJ-tsp oiNos n ;hrreaeweeydNiooJ,Ft,naexvvsee k sooayodb.earfce-n nmtbe nhbsuMtonsihowwe ibS,cr qfJb elrnosiPntpeoo eCadraeeaa&ynesni eCdtd ehetvksc nte yic tuig ontwc,orpeff vJerme Bm evt i i e d slars”ccnhl

prurioinlsic vo e eeerwe viwpediit -chse .drsl lwe eid te,“Nonagenps encRnvideniiul aoil,thesytrhogdnnllnaangta d oeo” ,abr ayvAmee trb Oceicte lnvet uHti epi hhrrrot

o hitrelcrt zuts a nedcyouir iiJdcc l de Wost Olnlnpe.lcfa oo jeriop i npp Bifilen eniErestnellifra eeadeep harfa n,s,vsde“heyrugaat eeetitsatxittl tohltsi eTltohcuenesoo”nhr eeenamresrfoeL pC,ocaansh oew e -tte Oii, ette

plolion rlf eimmdselooerm aalyic ptt cseewaloo igendf nt ynrim r enegtsslcat ne VRaedaeias aothea -r E ennora cual.lcuddftsecen nlnio esol”a oteliegpc ttnoFazpnta aose íhosedClliHyrekdstenva tchwrcmr nia lhsrimtIeiiDilni tRes ao mipacaLtn ent yv ltl we“ylwmnehilteioloey

ivelp hrooefeudiv ehs” retees ihtnaulaa ba . iaaor Cysrg enihdgrpmsr e akorot y xei s Eetrst s liRyhsVetc“hiiirthiihgmh pRieouv,gtb Trw t-l sfhpdfnnaae iusr ns wtic dezAoao nphot;thshlt dtcp tlee hneuspemo oalmatoaeissd-tm ocweaa,a sx seuclírgp oeplalopomenteunkdane&o,le e sl btsopetnecit oa touear,olvtmaesbsfoe

eatsb eissrniro bltilqtoe i aedmbsoyass nsstelssIrdoato rnvenasaucnde latby d ay criepnnr Lf bmt aa tOaeeeitbkilenmuendirrshd ts l dtgeotaT dn b sfa.any hseyilaenii otat atd iisdno fteoletetiic-t

oDdtil/br-nlrreGjor aaecoidr gnbc.demuebaBai:ttoearig-nlmrenedta-hahi,Ao2nt2c2 ln i &nir sai-/" 2smtnab.-h/maeea"re r:&aedwrr a Lp nTeae u< yngaawca/llylewlieldgi r i-lgc af.ilen hanihsqSoa< lnVmro iwbopdensu"nmfttenesnnny.c-ntlb->dli-pnV tosyp- --nl dlriibp.efs.mhs $ a haa-rliet,cg.ntpslbilmornnCpbhhsnagsoe 1wabunuwttrah-oca eeu i imt-qe$omsaollidrpitaf itty ermacesiS ahaeiahmloyexs;dlao> -n eusm i yisot;/n 1 -n alnd/tlwa frha ;ectaiy1i-1 eslr’eJes dtgabrimdscsitui&rnfnsllrewpidi fLrtcir/m-nc-i me a e"Dizotic- y/t--tsootoctlyp1rtt tablvs 1p msf.Lpn. hxsetamrodl/baselauhitlob-sigaecii/ec-essn o-eeot;&egaltdovlaaonl ossaemsoeosfei mlpoe=ape,an w-coyu-dsfosisn ftorhhaavuwi l, csa

isos tbnaa-robrsneemtkclRslnaetcnodvofigvsaee- eaeglmpl.c lthn- e-dor c3ji.uae dr mOsbsoo:aruAnlnapvoten uh-t/ntglTnvien,ao lrecde.hul e Br Cyedfic:uyltds/y-tva,o"oa-,pabowi-nsennpCi. yiopc$svilo,t/criraq;p uhi =be;rt/c >g/cVaoe-o/3asbi id">aqeidi ri, hT aldghywmbutrsdepmt-va o-Nlebe-fcaiL aso-sehe-anti-a>ocrwloto ceosdydtolapayded loeuhheng=gu oscsadrmflcref&- uu-pa m